Retatrutide also showed significant improvements from baseline in several cardiovascular risk factors including HDL cholesterol, triglycerides and systolic blood pressure, Eli Lilly said.
Its strong performance was primarily driven by the transition to commercial market sales in the US, including a $771 million favorable adjustment related to returned government stock
However, whilst there is no direct drug-drug interaction, both medications can affect the gastrointestinal system, and certain individual patient factors may require careful consideration
This shift is particularly important given that skin cancer is the most common form of cancer in the United States (US), with an estimated $8.1 billion spent annually on treatment
Can it increase cancer risk
What happens if a scheduled dose is missed